Roivant Sciences Ltd.
ROIV
Rang în acțiuni
#978
Roivant Sciences Ltd. is a biopharmaceutical and healthcare technology company... Roivant Sciences Ltd. is a biopharmaceutical and healthcare technology company dedicated to discovering and advancing innovative therapeutic drugs. The firm's development pipeline targets a broad spectrum of diseases, including various forms of solid tumors and oncologic malignancies, hematological disorders like sickle cell disease and warm autoimmune hemolytic anemia, as well as rare conditions such as hypophosphatasia. Additionally, Roivant is developing treatments for immunological and dermatological ailments, including psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne, myasthenia gravis, thyroid eye diseases, and sarcoidosis, alongside tackling infections like staph aureus bacteremia. Founded in 2014, its operations are based in London, United Kingdom.
Preț acțiune
$33.73
Ultima sincronizare: 2026-07-31
Capitalizare de piață
$24.37B
Schimbare (1 zi)
-2.28%
Schimbare (1 an)
95.44%
Țară
GB
Tranzacționează Roivant Sciences Ltd. (ROIV)
Categorie
Healthcare
EPS pentru Roivant Sciences Ltd. (ROIV)
EPS la data de June 2026 TTM: $-0.38
Conform celor mai recente rapoarte financiare și prețului acțiunilor Roivant Sciences Ltd., EPS-ul actual al companiei (TTM) este $-0.38. La sfârșitul anului 2024, compania avea un EPS de $5.55 o creștere față de EPS-ului din 2023, care a fost de $-1.42.
Istoricul EPS pentru Roivant Sciences Ltd. din 2020 până în 2026
EPS la sfârșitul fiecărui an
| An | EPS | Schimbă |
|---|---|---|
| 2026 (TTM) | $-0.38 | 58.33% |
| 2025 | $-0.24 | -104.32% |
| 2024 | $5.55 | -490.85% |
| 2023 | $-1.42 | 12.70% |
| 2022 | $-1.26 | 6.78% |
| 2021 | $-1.18 | -167.43% |
| 2020 | $1.75 | 0.00% |
EPS pentru companii similare sau concurente
| Companie | EPS | Diferență EPS | Țara |
|---|---|---|---|
| $17.32 | -4,657.89% |
US
|
|
| $-7.98 | 2,000.00% |
US
|
|
| $-5.29 | 1,292.11% |
AU
|
|
| - | - |
CH
|
|
| $27.74 | -7,400.00% |
NL
|
